CreditReports.dk
HomeScreen companies

PHARMA NORD EXPORT ApS Financials, key figures and credit report

CVR number: 70996510 Established 1982 Industry: 46 Wholesale trade
Company contact details
Sadelmagervej 30-32, 7100 Vejle webmaster@pharmanord.dk tel: 75857474
Gross profit 1 575.0 kDKK FY 2025 +18.1% vs 2024
EBIT 5 260.0 kDKK FY 2025 +881.6% vs 2024
Net debt 20 173.0 kDKK FY 2025 +30.1% vs 2024
Quick ratio 1.5 FY 2025 +0.4 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit1 701.571 614.121 442.161 334.001 575.00
Employee benefit expenses-2 269.08-1 655.17-1 866.22-2 126.00
Other operating expenses-63.00
Total depreciation- 487.56- 487.56- 487.56- 256.00- 252.00
Reduction in value of non-current assets375.004 000.00
EBIT-1 055.07- 528.62- 911.63- 673.005 260.00
Other financial income1 708.77183.21679.95701.00378.00
Other financial expenses- 448.50-1 184.77- 184.58- 389.00-1 162.00
Net income from associates (fin.)2 955.913 343.186 696.847 933.008 264.00
Pre-tax profit3 161.111 813.016 280.587 572.0012 740.00
Income taxes13.33296.5921.00- 112.00-1 224.00
Net earnings3 174.442 109.606 301.587 460.0011 516.00

Assets (kDKK)

2021
2022
2023
2024
2025
Intangible assets total
Land and waters34 983.8834 551.1934 118.515 749.0013 629.00
Buildings37 000.0041 000.00
Machinery and equipment178.36123.4868.60387.00409.00
Tangible assets total35 162.2434 674.6734 187.1143 136.0055 038.00
Holdings in group member companies8 740.767 466.4312 421.5916 415.0012 367.00
Investments total8 740.767 466.4312 421.5916 415.0012 367.00
Long term receivables total
Inventories total
Current amounts owed by group member comp.1 396.5020 365.8513 248.7414 146.00441.00
Prepayments and accrued income4.8012.0013.00
Current other receivables1 277.963 071.232 944.98461.009 810.00
Short term receivables total2 674.4623 437.0816 198.5214 619.0010 264.00
Other current investments26 452.37
Cash and bank deposits923.091 093.17256.895.0031.00
Cash and cash equivalents27 375.451 093.17256.895.0031.00
Balance sheet total (assets)73 952.9266 671.3563 064.1074 175.0077 700.00

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital200.00200.00200.00200.00200.00
Asset revaluation reserve7 575.667 497.447 419.236 240.00
Shares repurchased15 000.0015 000.008 000.00
Other reserves1 228.225 223.001 116.00
Retained earnings32 993.0521 241.2922 234.7316 387.0019 856.00
Profit of the financial year3 174.442 109.606 301.587 460.0011 516.00
Shareholders equity total43 943.1446 048.3437 383.7644 270.0046 928.00
Provisions7 329.617 027.367 086.997 154.0010 098.00
Non-current loans from credit institutions11 253.4210 574.2210 023.809 468.0013 635.00
Non-current liabilities total11 253.4210 574.2210 023.809 468.0013 635.00
Current loans from credit institutions1 044.391 122.92607.35556.005 708.00
Current trade creditors55.9755.97588.901 089.00123.00
Current owed to participating5 250.005 481.00197.00
Current owed to group member7 812.06664.00
Short-term deferred tax liabilities39.67114.00
Other non-interest bearing current liabilities2 474.651 842.542 123.306 157.00233.00
Current liabilities total11 426.753 021.448 569.5513 283.007 039.00
Balance sheet total (liabilities)73 952.9266 671.3563 064.1074 175.0077 700.00
Page generated